Journal of Rhinology 2008;15(1):7-12.
Published online May 31, 2008.
Bone Marrow-Derived Mesenchymal Stem Cells for Regenerative Medicine
Dong Joon Park
Department of Otolaryngology-Head and Neck Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea.
골수 줄기세포를 이용한 재생의학
연세대학교 원주의과대학 이비인후과학교실
Bone marrow-derived mesenchymal stem cells (BMMSCs) can be differentiated into a variety of cell types, offering promising approaches for stem-cell mediated tissue regeneration. The facial region contains many specific tissues including bone, cartilage, muscle and neurons. Defect or dysfunction of the facial tissues after cancer surgery, trauma, congenital malformations has a huge influence on the patient's life. Therefore functional reconstruction of damaged tissue is highly sought after. BMMSCs are one of the better characterized postnatal stem cell population and most considered for utilization during cell based clinical therapies. The current review describes what is known about BMMMSCs and their capacity for use as regenerative medicine in the area of otolaryngology.
Key Words: Mesenchymal stem cells;Tissue engineering;Regenerative medicine

METRICS Graph View
  • 59 View
  • 0 Download
Related articles

Editorial Office
101 Hyundai ESA Apt., 20, Hyoryeong-ro 77-gil, Seocho-gu, Seoul 06628, Republic of Korea
Tel: +82-2-3461-9945    Fax: +82-2-3461-9947    E-mail:                

Copyright © 2020 by Korean Rhinologic Society. All rights reserved.

Close layer
prev next